The Association Between Fasting Plasma Glucose and All-cause and Cause-specific Mortality by Gender: The Rural Chinese Cohort Study
Overview
Authors
Affiliations
Background: To evaluate the association between fasting plasma glucose (FPG) and mortality by gender.
Methods: A total of 17 248 eligible participants from a rural Chinese prospective cohort population were included. The same questionnaire interview and anthropometric and laboratory measurements were performed at both baseline (2007-2008) and follow-up (2013-2014). Participants were classified according to baseline FPG and diabetic status by sex. Restricted cubic splines and Cox proportional-hazards regression models, estimating hazard ratio (HR) and 95% confidence interval (CI), were used to assess the FPG-mortality relation.
Results: During the 6-year follow-up, 618 men and 489 women died. The FPG-mortality relation was J shaped for both sexes. For men, risk of all-cause and noncardiovascular disease (CVD)/noncancer mortality was greater with low fasting glucose (LFG) than with normal fasting glucose (adjusted HR [aHR] 1.60; 95% CI, 1.05-2.43; and aHR 2.16; 95% CI, 1.15-4.05). Men with diabetes mellitus (DM) showed increased risk of all-cause (aHR 2.04; 95% CI, 1.60-2.60), CVD (aHR 1.98; 95% CI, 1.36-2.89), and non-CVD/noncancer mortality (aHR 2.62; 95% CI, 1.76-3.91). Men with impaired fasting glucose (IFG) had borderline risk of CVD mortality (aHR 1.34; 95% CI, 1.00-1.79). Women with LFG had increased risk of non-CVD/noncancer mortality (aHR 2.27; 95% CI, 1.04-4.95), and women with DM had increased risk of all-cause (aHR 1.73; 95% CI, 1.35-2.23), CVD (aHR 1.76; 95% CI, 1.24-2.50), and non-CVD/noncancer mortality (aHR 1.97; 95% CI, 1.27-3.08).
Conclusions: LFG is positively associated with all-cause mortality risk in rural Chinese men but not in women.
Gao Q, Wang Q, Gan Z, Wang M, Lu D, Zhan B PLoS One. 2024; 19(11):e0311150.
PMID: 39561141 PMC: 11575760. DOI: 10.1371/journal.pone.0311150.
Qiu S, Liu X, Lei L, Liang H, Li X, Wang Y J Diabetes. 2024; 16(6):e13567.
PMID: 38769875 PMC: 11106591. DOI: 10.1111/1753-0407.13567.
Chen X, Ding J, Shi Z, Bai K, Shi S, Tian Q BMC Public Health. 2024; 24(1):1335.
PMID: 38760762 PMC: 11102116. DOI: 10.1186/s12889-024-18823-0.
Li W, Wen C, Li W, Ying Z, Pan S, Li Y Diabetol Metab Syndr. 2023; 15(1):169.
PMID: 37574540 PMC: 10424387. DOI: 10.1186/s13098-023-01146-2.
Xu Y, Zhong Z, Li Y, Li Z, Zhou Y, Li Z Clin Kidney J. 2023; 16(4):727-734.
PMID: 37007694 PMC: 10061421. DOI: 10.1093/ckj/sfac266.